[1] |
SUN Qiyue, ZHAO Ronghua, BAO Lei, GUO Shanshan, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing.
Safe doses of Lingyang Ganmao oral liquid for children based on the multi-animal model
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 121-126.
|
[2] |
FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong.
Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184.
|
[3] |
LI Yingfen, HAN Lei.
Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
|
[4] |
GAO Yuan, SHI Wei, XIAO Xiaohe, BAI Zhaofang, WANG Jiabo.
Research progress on the animal models of idiosyncratic drug-induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(1): 33-39.
|
[5] |
LI Xingren, SHEN Aizong, SU Dan.
Evaluation of the rationality of proton pump inhibitors in preventing perioperative stress related mucosal disease in biliary and pancreatic surgery
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1022-1026.
|
[6] |
SHI Xiangfen, SUN Zhiyong, ZHANG Xufeng, LU Xiaojing, DU Shuzhang, ZHANG Xiaojian.
Whole process management of narcotic drugs and psychotropic drugs based on intelligent information management system
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 899-903.
|
[7] |
HUO Yanfei, TIAN Yuejie, XU Lili, XIE Yanjun, CHANG Hong, SUN Chunxiao, LI Xia.
535 reports of new and serious adverse drug reactions caused by preparations of lappaconitine hydrobromide
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 921-926.
|
[8] |
LIU Jing, XIA Liang, ZHANG Shijie.
Pharmaceutical care of a patient with acute pancreatitis complicated with multiple drug allergy undergoing drug stimulation test
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 822-824.
|
[9] |
QIN Guilan, ZHOU Muzi, JI Zhaoshuai, MAO Qiantai, AI Chao.
One case of acute constipation induced by semaglutide injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 833-835.
|
[10] |
ZHAO Xuan, GUO Jing, CHEN Ning, MEI Long, ZHENG Tingting, ZHANG Lifang, ZHANG Wei.
Discuss the safety management of medical toxic drugs in medical institutions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(6): 705-708.
|
[11] |
FAN Xiucong, DONG Xiaohui, CHEN Danxia, BAO Siwei, MA Yabin.
Pharmaceutical care of a patient with Clostridium difficile infection and urinary tract infection during pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 579-582.
|
[12] |
HUO Peiqiong, ZHENG Peng, SU Zhenhao.
Pharmacovigilance in retail pharmacies for special or major diseases
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 428-432.
|
[13] |
ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, Li Guiping, WANG Daohan, LI Shuran, ZHANG Jingsheng, PANG Bo, XU Yingli, ZHOU Lirun, BAO Yanyan, CHEN Mengping, GUO Shanshan, CUI Xiaolan.
Effect of Jinzhen oral liquid on the model of human coronavirus pneumonia and fever epidemic immature adult mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 248-252.
|
[14] |
HE Hui, CHAI Yuanyuan, XU Yunxia, YU Qinwei, HUNAG Xin, ZHANG Luyong, JINAG Zhenzhou.
Simultaneous determination of acetaminophen and its toxicity related metabolite acetaminophen-cysteine in mouse plasma by LC-MS/MS
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 266-272.
|
[15] |
YIN Jinjun, WANG Shuwei, SHAO Jiangchao, WANG Bing.
Drug use evaluation of bevacizumab injection based on weighted TOPSIS method
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(12): 1421-1426.
|